Share
PDFResearch ethics
Paper
Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
Other content recommended for you
- Access to investigational medicinal products for minors in Europe: ethical and regulatory issues in negotiating children's access to investigational medicines
- Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
- Expanded access: growing importance to public health
- Trump signs bill to give patients right to try drugs
- Emerging immunotherapies in multiple myeloma
- Plasma cell leukaemia with t(11;14) not responsive to venetoclax
- Shortage of essential antimicrobials: a major challenge to global health security
- First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
- Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of ‘compassionate therapies’ in times of catastrophic pandemics
- Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program